NPPA Says No Recall or Relabelling Needed for Cancer Drugs Under New Trade Margin Cap, Issues TMR Compliance FAQs
NPPA has clarified that cancer-drug packs already in the market need not be recalled or relabelled when 30% trade-margin-capped prices for 137 drugs take effect on 9 November, provided retailers charge the revised MRP.
